These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 34355471)

  • 21. Positive predictive value of a single nucleotide polymorphism (SNP)-based NIPT for aneuploidy in twins: Experience from clinical practice.
    Kantor V; Mo L; DiNonno W; Howard K; Palsuledesai CC; Parmar S; Chithiwala Z; Jelsema R; Xu W; Hedriana HL
    Prenat Diagn; 2022 Dec; 42(13):1587-1593. PubMed ID: 36336878
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical application of noninvasive prenatal testing for the detection of trisomies 21, 18, and 13: a hospital experience.
    Zhou Q; Pan L; Chen S; Chen F; Hwang R; Yang X; Wang W; Jiang J; Xu J; Huang H; Xu C
    Prenat Diagn; 2014 Nov; 34(11):1061-5. PubMed ID: 24899146
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Analysis of non-invasive prenatal testing in 14 047 cases of advanced age pregnant women].
    Lu Z; Tian L; Ying H; Huang F
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Jun; 37(6):613-616. PubMed ID: 32472535
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Non-invasive prenatal testing for the detection of trisomies 21, 18, and 13 in pregnant women with various clinical indications: A multicenter observational study of 1,854,148 women in China.
    Xiang L; Zhu J; Deng K; Li Q; Tao J; Li M; Wang Y; Yuan X; Yao Y; Li X
    Prenat Diagn; 2023 Jul; 43(8):1036-1043. PubMed ID: 36639250
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical experience of noninvasive prenatal testing with cell-free DNA for fetal trisomies 21, 18, and 13, in a general screening population.
    Fairbrother G; Johnson S; Musci TJ; Song K
    Prenat Diagn; 2013 Jun; 33(6):580-3. PubMed ID: 23494956
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of cell-free DNA-based non-invasive prenatal testing in a National Health Service Regional Genetics Laboratory.
    Togneri FS; Kilby MD; Young E; Court S; Williams D; Griffiths MJ; Allen SK
    Genet Res (Camb); 2019 Dec; 101():e11. PubMed ID: 31813398
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outcomes of 8 Years of Noninvasive Prenatal Testing at Nippon Medical School Hospital.
    Kawabata I; Sahara T; Hiraoka S; Yonezawa M; Miyake H; Suzuki S; Yamada T
    J Nippon Med Sch; 2022 Nov; 89(5):520-525. PubMed ID: 35644554
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Next-generation sequencing: a follow-up of 36,913 singleton pregnancies with noninvasive prenatal testing in central China.
    Lu W; Huang T; Wang XR; Zhou JH; Yuan HZ; Yang Y; Huang TT; Liu DP; Liu YQ
    J Assist Reprod Genet; 2020 Dec; 37(12):3143-3150. PubMed ID: 33094428
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clinical application of expanded noninvasive prenatal testing for fetal chromosome abnormalities].
    Chen YS; Wang FF; Lu LKY; Ni YH; Wang Q; Ying CM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1491-1495. PubMed ID: 34963249
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Noninvasive detection of fetal trisomy 21: systematic review and report of quality and outcomes of diagnostic accuracy studies performed between 1997 and 2012.
    Mersy E; Smits LJ; van Winden LA; de Die-Smulders CE; ; Paulussen AD; Macville MV; Coumans AB; Frints SG
    Hum Reprod Update; 2013; 19(4):318-29. PubMed ID: 23396607
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Clinical evaluation of true and false positive Z values among high-risk cases screened by non-invasive prenatal testing].
    Mo J; Ren J; Yang L; Shen X; Zhao D; Xiao Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2022 Nov; 39(11):1187-1191. PubMed ID: 36317201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TRIDENT-2: National Implementation of Genome-wide Non-invasive Prenatal Testing as a First-Tier Screening Test in the Netherlands.
    van der Meij KRM; Sistermans EA; Macville MVE; Stevens SJC; Bax CJ; Bekker MN; Bilardo CM; Boon EMJ; Boter M; Diderich KEM; de Die-Smulders CEM; Duin LK; Faas BHW; Feenstra I; Haak MC; Hoffer MJV; den Hollander NS; Hollink IHIM; Jehee FS; Knapen MFCM; Kooper AJA; van Langen IM; Lichtenbelt KD; Linskens IH; van Maarle MC; Oepkes D; Pieters MJ; Schuring-Blom GH; Sikkel E; Sikkema-Raddatz B; Smeets DFCM; Srebniak MI; Suijkerbuijk RF; Tan-Sindhunata GM; van der Ven AJEM; van Zelderen-Bhola SL; Henneman L; Galjaard RH; Van Opstal D; Weiss MM;
    Am J Hum Genet; 2019 Dec; 105(6):1091-1101. PubMed ID: 31708118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Positive predictive value estimates for cell-free noninvasive prenatal screening from data of a large referral genetic diagnostic laboratory.
    Petersen AK; Cheung SW; Smith JL; Bi W; Ward PA; Peacock S; Braxton A; Van Den Veyver IB; Breman AM
    Am J Obstet Gynecol; 2017 Dec; 217(6):691.e1-691.e6. PubMed ID: 29032050
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Noninvasive prenatal testing in routine clinical practice for a high-risk population: Experience from a center.
    Qi G; Yi J; Han B; Liu H; Guo W; Shi C; Yin L
    Medicine (Baltimore); 2016 Oct; 95(41):e5126. PubMed ID: 27741136
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical performance of non-invasive prenatal testing for trisomies 21, 18 and 13 in twin pregnancies: A cohort study and a systematic meta-analysis.
    He Y; Wang Y; Li Z; Chen H; Deng J; Huang H; He X; Zeng W; Liu M; Huang B; Chen P
    Acta Obstet Gynecol Scand; 2020 Jun; 99(6):731-743. PubMed ID: 32166736
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Noninvasive Prenatal Testing for Trisomies 21, 18, and 13, Sex Chromosome Aneuploidies, and Microdeletions in Average-Risk Pregnancies: A Cost-Effectiveness Analysis.
    Xie X; Wang M; Goh ES; Ungar WJ; Little J; Carroll JC; Okun N; Huang T; Rousseau F; Dougan SD; Tu HA; Higgins C; Holubowich C; Sikich N; Dhalla IA; Ng V
    J Obstet Gynaecol Can; 2020 Jun; 42(6):740-749.e12. PubMed ID: 32008974
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Noninvasive prenatal testing: impact on genetic counseling, invasive prenatal diagnosis, and trisomy 21 detection.
    Wax JR; Cartin A; Chard R; Lucas FL; Pinette MG
    J Clin Ultrasound; 2015 Jan; 43(1):1-6. PubMed ID: 25303161
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fetal fraction-based risk algorithm for non-invasive prenatal testing: screening for trisomies 13 and 18 and triploidy in women with low cell-free fetal DNA.
    McKanna T; Ryan A; Krinshpun S; Kareht S; Marchand K; Grabarits C; Ali M; McElheny A; Gardiner K; LeChien K; Hsu M; Saltzman D; Stosic M; Martin K; Benn P
    Ultrasound Obstet Gynecol; 2019 Jan; 53(1):73-79. PubMed ID: 30014528
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Analysis to the failure rate and causes of noninvasive prenatal testing based on high-throughput sequencing].
    Wang W; Duan H; Ding W; Zhang Y; Zhu R; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 Dec; 38(12):1171-1175. PubMed ID: 34839500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.